Atypical presentation and pathogenesis of a macaque lymphocryptoviral-associated B-cell lymphoma in a cynomolgus monkey.


Journal

Veterinary clinical pathology
ISSN: 1939-165X
Titre abrégé: Vet Clin Pathol
Pays: United States
ID NLM: 9880575

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 19 02 2019
revised: 18 04 2019
accepted: 28 05 2019
pubmed: 6 2 2020
medline: 26 1 2021
entrez: 4 2 2020
Statut: ppublish

Résumé

We report the unique pathogenesis and presentation of a rapidly progressive B-cell lymphoma in a 3-year-old female cynomolgus monkey on day 50 of a 13-week toxicity study. Clinical pathology evaluation revealed a marked leukocytosis with bicytopenia. A serum protein electrophoresis was consistent with monoclonal gammopathy. The architecture of the lymph node, spleen, and thymus were variably effaced by neoplastic cells, which also infiltrated other tissues. Immunohistochemistry of the affected tissues confirmed a predominant population of CD20+, CD79a+, CD3-, CD68-, and CD34-neoplastic cells. The full data best support a diagnosis of Stage V lymphoma. Nextgen sequencing and negative prestudy serology results suggested a recent infection by macaque lymphocryptovirus (mLCV) with a unique transcriptional profile comparable with a rarely observed direct LCV infection model. This infection model might be associated with a temporary lack of an LCV antigen-specific cytotoxic T-cell adaptive immune response. Consistent with the established mechanisms of LCV-related lymphoproliferation, MYC and BCL2L11 gene expression were increased and decreased, respectively. While there was no overt immunosuppression, immunophenotyping revealed the index animal had a relatively low NK cell count, which further decreased by >50% on day 24 of the study. In addition to the temporary lack of adaptive immunity, the low NK cell counts were suggestive of an impaired innate immunity to control the virally-transformed cells and the subsequent unchecked lymphoproliferation. To our knowledge, this is the first report of a Stage V lymphoma with a unique pathogenesis in an otherwise immunocompetent cynomolgus monkey.

Identifiants

pubmed: 32009251
doi: 10.1111/vcp.12822
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-136

Subventions

Organisme : Genentech

Informations de copyright

© 2020 American Society for Veterinary Clinical Pathology.

Références

Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992;41(Suppl 2):97-101.
Krauss RM, Grunfeld C, Doerrler WT, Feingold KR. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology. 1990;127:1016-1021.
Carville A, Mansfield KG. Comparative pathobiology of macaque lymphocryptoviruses. Comp Med. 2008;58:57-67.
Cho Y, Ramer J, Rivailler P, et al. An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc Natl Acad Sci USA. 2001;98:1224-1229.
Ensser A, Fleckenstein B. T-cell transformation and oncogenesis by gamma2-herpesviruses. Adv Cancer Res. 2005;93:91-128.
Hubbard GB, Mone JP, Allan JS, et al. Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci. 1993;43:301-309.
Kahnt K, Matz-Rensing K, Hofmann P, Stahl-Hennig C, Kaup FJ. SIV-associated lymphomas in rhesus monkeys (Macaca mulatta) in comparison with HIV-associated lymphomas. Vet Pathol. 2002;39:42-55.
Lapin BA, Yakovleva LA. Spontaneous and experimental malignancies in non-human primates. J Med Primatol. 2014;43:100-110.
Paramastri YA, Wallace JM, Salleng KJ, Wilkinson LM, Malarkey DE, Cline JM. Intracranial lymphomas in simian retrovirus-positive Macaca fascicularis. Vet Pathol. 2002;39:399-402.
Sakakibara I, Sugimoto Y, Sasagawa A, et al. Spontaneous malignant lymphoma in an African green monkey naturally infected with simian T-lymphotropic virus (STLV). J Med Primatol. 1986;15:311-318.
Yee JL, Vanderford TH, Didier ES, et al. Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony management. J Med Primatol. 2016;45:55-78.
Kurth J, Hansmann ML, Rajewsky K, Kuppers R. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci USA. 2003;100:4730-4735.
Wood CD, Veenstra H, Khasnis S, Gunnell A, Webb HM, Shannon-Lowe C, Andrews S, Osborne CS, West MJ. MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. eLife. 2016;5, e18270. https://doi.org/10.7554/eLife.18270
Kol A, Christopher MM, Skorupski KA, Tokarz D, Vernau W. B-cell lymphoma with plasmacytoid differentiation, atypical cytoplasmic inclusions, and secondary leukemia in a dog. Vet Clin Pathol. 2013;42:40-46.
Vockerodt M, Yap LF, Shannon-Lowe C, et al. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235:312-322.
Williams H, McAulay K, Macsween KF, et al. The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol. 2005;129:266-274.
Chijioke O, Landtwing V, Munz C. NK cell influence on the outcome of primary Epstein-Barr virus infection. Front Immunol. 2016;7:323.
Geiger TL, Sun JC. Development and maturation of natural killer cells. Curr Opin Immunol. 2016;39:82-89.
Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol Oncol Stem Cell Ther. 2015;8:47-55.
Roschewski M, Wilson WH. EBV-associated lymphomas in adults. Best Pract Res Clin Haematol. 2012;25:75-89.
Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102:83-87.
Stuhlmann-Laeisz C, Oschlies I, Klapper W. Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how? J Hematop. 2014;7:165-170.
Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K. Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood. 2016;127:965-970.
Qi ZL, Han XQ, Hu J, et al. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues. Mol Med Rep. 2013;7:89-92.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-2390.
Nicolae A, Pittaluga S, Abdullah S, et al. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood. 2015;126:863-872.

Auteurs

Adeyemi O Adedeji (AO)

Genentech, A Member of the Roche Group, South San Francisco, CA, USA.

Vimala Vemireddi (V)

Covance Laboratories, Inc., Princeton, NJ, USA.

Niraj Tripathi (N)

Covance Laboratories, Inc., Princeton, NJ, USA.

Steffen Durinck (S)

Genentech, A Member of the Roche Group, South San Francisco, CA, USA.

Jonathan M Maher (JM)

Genentech, A Member of the Roche Group, South San Francisco, CA, USA.

Domagoj Vucic (D)

Genentech, A Member of the Roche Group, South San Francisco, CA, USA.

Wendy Halpern (W)

Genentech, A Member of the Roche Group, South San Francisco, CA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH